Comparison of clinical and biochemical characteristics of patients included in the study divided according to whether they were dead or alive at 12 months
| Dead (n = 64) | Alive (n = 244) | p Value | Likelihood ratio | |
|---|---|---|---|---|
| GI, gastrointestinal; INR, international normalisation ratio; MELD, model for end-stage liver disease; SBP, spontaneous bacterial peritonitis. | ||||
| *As defined by serum creatinine ⩾1.5 mg/dl. | ||||
| †All patients had type 2 hepatorenal syndrome. | ||||
| Age (years) | 52 (10) | 52 (9) | 0.9 | |
| Ascites | 60 (94%) | 211 (87%) | ||
| Controlled | 14 (23%) | 98 (46%) | 0.001 | 9.3 |
| Uncontrolled | 46 (77%) | 113 (54%) | ||
| Hepatic encephalopathy | 38 (59%) | 107 (44%) | 0.02 | 4.7 |
| GI bleeding | 20 (21%) | 71 (29%) | 0.42 | 0.1 |
| SBP | 19 (30%) | 64 (26%) | 0.348 | 0.28 |
| Renal failure* | 13 (20%) | 26 (11%) | 0.04 | 3.8 |
| Hepatorenal syndrome† | 9 (15%) | 11 (5%) | 0.01 | 6.38 |
| Bilirubin (mg/dl) | 6.7 (7.1) | 3.7 (3.5) | 0.002 | |
| Albumin (g/l) | 28 (5) | 31 (5) | 0.000 | |
| INR | 2 (1) | 1.6 (0.8) | 0.03 | |
| Creatinine (mg/dl) | 1.2 (1.1) | 1.2 (1.0) | 0.453 | |
| Sodium (mEq/l) | 132 (6) | 136 (4) | 0.000 | |
| MELD score | 21 (6) | 16 (5) | 0.000 | |